IndraLab

Statements


| 3

reach
"Furthermore, tofacitinib inhibited NFkappaBp65 in PsA explants and PsAFLS, a key transcriptional factor in the inflamed joint (XREF_FIG E)."

reach
"Mechanistically, we demonstrate that tofacitinib suppresses ox-LDL-mediated activation of NF-kappaB inhibitor alpha (IkappaB-alpha), accumulation of nuclear p65 and activation of nuclear factor kappaB (NF-kappaB) promoter, indicating that tofacitinib inhibits NF-kappaB activation."

reach
"XREF_BIBR In this study, tofacitinib inhibited pSTAT1, pSTAT3 and NFkappaBp65 in PsAFLS and PsA explants, an effect that was paralleled by induction of both SOCS3 and PIAS3."